Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Systemic Lupus Erythematosus
and you are
between 15 and 49
years old
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

This project is a multicenter, randomized, placebo-controlled, double-blind clinical trial that is designed to test whether treating patients who are at risk for development of lupus with hydroxychloroquine can slow accumulation of disease features. Effects on clinical progression of symptoms, patient-reported outcomes and changes in the immune markers of response will be measured and toxicity of the treatment will be assessed. This trial is a first step in testing a prevention strategy for lupus.

Provided treatments

  • Drug: Hydroxychloroquine
  • Drug: Placebo Oral Capsule
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT03030118. The sponsor of the trial is Milton S. Hershey Medical Center and it is looking for 240 volunteers for the current phase.
Official trial title:
Study of Anti-Malarials in Incomplete Lupus Erythematosus